Clinical trial
A Multicenter, Double Blind, Randomised, Parallel Study to Assess Efficacy and Tolerability After Single Administration of Ketoprofen Lysine Salt 40 mg Granules vs Placebo in Subjects With Acute Pain Syndrome After Removal of Molar Teeth
NCT03836807 is registered in ClinicalTrials.gov with Dompé Farmaceutici S.p.A as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double Blind, Randomised, Parallel Study to Assess Efficacy and Tolerability After Single Administration of Ketoprofen Lysine Salt 40 mg Granules vs Placebo in Subjects With Acute Pain Syndrome After Removal of Molar Teeth
- Lead sponsor
- Dompé Farmaceutici S.p.A
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 4, 2018
- Completion date
- December 21, 2018
- Enrollment
- 70 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.